"The plaintiffs have requested a Maryland federal court as the court to consolidate and centralize the litigation under one judge," according to Attorney Shezad Malik, who represents several hip implant failure plaintiffs.
The federal judicial system uses multidistrict litigation as a mechanism to help manage complex lawsuits related to each other by transferring those cases to one federal judge for pre-trial discovery in advance of trial.
Smith & Nephew, a global medical technology company based in England, is facing hundreds of lawsuits over its BHR and R3 line of hip implant devices.
The lawsuits concern the premature failure of Smith & Nephew's BHR and R3 metal-on-metal hip implant devices. Metal-on-metal hip replacement systems consist of a metal ball (femoral head), a metal femoral stem in the thighbone and a metal cup in the hip bone (acetabular component).
Smith & Nephew recalled the R3 in June 2012 due to high failure rates and took the BHR device off the market in June 2015 due to similar high failure rates, particularly in women and patients with smaller hip joints, according to Malik.
READ MORE DEFECTIVE HIP IMPLANT LEGAL NEWS
Hip implant devices are typically expected to last between 10 and 20 years but Taylor allegedly had to undergo revision surgery just eight years after receiving the hip implant due to hip pain and premature hip failure.
The FDA approved the BHR hip implant in May 2006, requiring Smith & Nephew to meet post-marketing surveillance and reporting requirements designed to ensure that in real-world use, the hip replacement system was safe and effective. However, Taylor's lawsuit alleges that the company failed to do so.
"Smith & Nephew knew for years about reports of complications with Birmingham hip resurfacing, including revision surgeries and failures, yet failed to adequately inform the doctors or patients," says Malik.